Elite Pharmaceuticals Inc (ELTP) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Suppliers, else..
 
Elite Pharmaceuticals Inc   (ELTP)
 

Elite Pharmaceuticals Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ELTP Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 11.11 % 7.43 % 7.83 % 9.17 %
Q / Q Revenue Growth (Q3 MRQ) 23.88 % 1.71 % 1.97 % 4.22 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 18.42 % 8.53 % 7.66 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 2.86 % 4.29 % 3.54 % 2.08 %
Revenue 5 Year Average Growth 42.45 % 7.52 % 8.67 % 13.63 %


ELTP's Growth Comparisons in II. Quarter 2026




Elite Pharmaceuticals Inc 's 11.11% year on year top-line increase in the second quarter 2026 to 40 millions, decelerating from Elite Pharmaceuticals Inc 's growth trends, but compares favorably to the 7.43% growth in the Major Pharmaceutical Preparations industry, and 7.83% growth in the Healthcare sector. Despite modest Sales rises in the Healthcare sector and in the Major Pharmaceutical Preparations industry, Elite Pharmaceuticals Inc reported above average market Sales growth.

Company's sequential top-line increase was 23.88% from the first quarter. Average annual sales rise for Elite Pharmaceuticals Inc is 42.45%, while S & P 500's average yearly sales growth is 13.63% over the five years, including only Businesses with the second quarter 2026 Results.

ELTP Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Direct Sales to Wholesalers
-
111.21 %
Indirect Sales to Wholesalers
-
138.83 %
Abbreviated New Drug Applications Revenue
-
124.73 %
Scheduled Products Manufacturing Fees
-
122.84 %
Un Scheduled Products Manufacturing Fees
-
136.88 %
Total
11.11 %
23.88 %


Growth Rates of ELTP's Income in the second quarter 2026


ELTP Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 20.84 % 28.11 % 20.67 % 29.95 %
Sequential Operating Income Change (Q3 MRQ) 31.82 % 13.61 % 3.9 % 4.5 %
Y / Y Operating Income Growth (Q3 TTM) -13.07 % 48.32 % 37.37 % 14.37 %
Sequential Operating Income Growth (Q3 TTM) 4.9 % 13.66 % 9.84 % 6.96 %
Operating Income 5 Year Avg. Change 87.76 % 14.12 % 10.27 % 18.8 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 26.39 % - - 21.83 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) 193.01 % - - 11.13 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 361.42 % -58.4 % -17.98 % 16.46 %
Sequential Income from Cont. Ops. Change (Q3 TTM) 5.96 % -8.16 % -5.36 % 6.05 %
Income from Cont. Ops. 5 Year Avg. Change 54.55 % 14.58 % 8.91 % -28.64 %

ELTP Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 26.39 % -22.25 % 14.13 % 21.56 %
Q / Q Net Income Growth (Q3 MRQ) 193.01 % -35.92 % -30.05 % 11.12 %
Y / Y Net Income Change (Q3 TTM) 332.97 % 52.27 % 54.24 % 16.59 %
Sequential Net Income Change (Q3 TTM) 6.38 % 5.96 % 10.97 % 6.03 %
Net Income 5 Year Avg. Growth 54.55 % 14.16 % 9.09 % 23.95 %

ELTP's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 100 % - - 21.83 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) 100 % - - 11.13 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 1253.55 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) 14.29 % - - -99.7 %
EPS from Cont. Ops. 5 Year Avg. Growth 31.95 % -0.46 % 8.91 % -28.64 %



ELTP EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 0 % -33.21 % 14.13 % -28.64 %
Q / Q EPS Net Growth (Q3 MRQ) 0 % -26.39 % -30.05 % 11.12 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - -99.97 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) 0 % - - -99.87 %
EPS Net 5 Year Avg. Change 24.57 % 14.16 % 9.09 % 23.95 %



Reporting flat EPS in the second quarter, at $ 0.01, Elite Pharmaceuticals Inc performing better than the -33.21% Major Pharmaceutical Preparations industry but underperformed the 14.13% EPS improvement in the Healthcare sector. Slow second quarter 2026 income per share, in Major Pharmaceutical Preparations industry and within the Healthcare sector, were portrayed in Elite Pharmaceuticals Inc results which underperformed overall market.

Sequentially company's EPS were unchanged from the first quarter results. . Looking into annual growth, income per share grew by 24.57% on average in the last five years, while the S & P 500's including only the businesses with the second quarter 2026 financial results, average yearly income per share growth is 23.95%.

ELTP Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) - -19.02 % -12.18 % 2 %
Sequential Free Cash Flow Change (Q3 MRQ) - -52.86 % -35.09 % 22.32 %
Y / Y Free Cash Flow Change (Q3 TTM) -65.3 % 9.88 % 11.19 % 11.81 %
Sequential Free Cash Flow Change (Q3 TTM) -53.96 % 2.19 % 2.28 % 2.41 %
Free Cash Flow 5 Year Avg. Change 50.75 % 0.88 % 0.41 % 1.8 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - -93.37 % 1035.72 %
Sequential Net Cash Flow Change (Q3 MRQ) - - -99.11 % -
Y / Y Net Cash Flow Change (Q3 TTM) - -21.35 % -24.15 % -
Sequential Net Cash Flow Change (Q3 TTM) - -44.35 % -25.78 % -
Net Cash Flow 5 Year Avg. Change 55.1 % 29.88 % 6.46 % 1.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 608.58 % 19.22 % 7.48 % 23.41 %
Sequential Capital Expenditures Change (Q3 MRQ) -9.49 % 18.85 % 16.64 % 18.97 %
Y / Y Capital Expenditures Change (Q3 TTM) 211.14 % 21 % 12.06 % 23.88 %
Sequential Capital Expenditures Change (Q3 TTM) 23.14 % 11.24 % 7.5 % 7.02 %
Capital Expenditures 5 Year Avg. Change 22.91 % 7.88 % 8.63 % 14.2 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.